Search


 
Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 28 (Search time: 0.001 seconds).
Item hits:
First PublishedTitleAuthor(s)Type
Dec-2011Eμ/miR-125b transgenic mice develop lethal B-cell malignanciesEnomoto, Y; Kitaura, J; Kato, N; Nishimura, K; Takahashi, M; Kitamura, T; Hatakeyama, K; Watanuki, J; Shimanuki, M; Nakakuma, H; Sonoki, T; Akasaka, T; Dyer, MJS; Taniwaki, M; Haferlach, C; Siebert, R; Asou, N; Aburatani, H; Kitamura, TJournal Article
Dec-2011E mu/miR-125b transgenic mice develop lethal B-cell malignanciesEnomoto, Y; Kitaura, J; Hatakeyama, K; Watanuki, J; Akasaka, T; Kato, N; Shimanuki, M; Nishimura, K; Takahashi, M; Taniwaki, M; Haferlach, C; Siebert, R; Dyer, MJS; Asou, N; Aburatani, H; Nakakuma, H; Kitamura, T; Sonoki, TJournal Article
Aug-2012Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the diseaseRoyo, C; Navarro, A; Clot, G; Salaverria, I; Gine, E; Jares, P; Colomer, D; Wiestner, A; Wilson, WH; Vegliante, MC; Fernandez, V; Hartmann, EM; Trim, N; Erber, WN; Swerdlow, SH; Klapper, W; Dyer, MJS; Vargas-Pabon, M; Ott, G; Rosenwald, A; Siebert, R; Lopez-Guillermo, A; Campo, E; Bea, SJournal Article
Dec-2011Bilateral subdural hygromas following intrathecal methotrexateLokireddy, P; Dyer, MJSJournal Article
25-Nov-2010The PARP inhibitor olaparib induces significant killing of ATM-deficientlymphoid tumor cells in vitro and in vivoWeston, VJ; Oldreive, CE; Skowronska, A; Kearns, P; Moss, PAH; Taylor, AMR; Stankovic, T; Oscier, DG; Pratt, G; Dyer, MJS; Smith, G; Powell, JE; Rudzki, ZJournal Article
Sep-2012High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphomaFresquet, V; Robles, EF; Parker, A; Martinez-Useros, J; Mena, M; Malumbres, R; Agirre, X; Catarino, S; Arteta, D; Osaba, L; Mollejo, M; Hernandez-Rivas, JM; Jose Calasanz M; Daibata, M; Dyer, MJS; Prosper, F; Vizcarra, E; Piris, M-A; Oscier, D; Angel Martinez-Climent JJournal Article
26-Jul-2012Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemiaSlager, SL; Skibola, CF; Di Bernardo MC; Conde, L; Broderick, P; McDonnell, SK; Goldin, LR; Croft, N; Holroyd, A; Harris, S; Riby, J; Serie, DJ; Kay, NE; Call, TG; Bracci, PM; Halperin, E; Lanasa, MC; Cunningham, JM; Leis, JF; Morrison, VA; Spector, LG; Vachon, CM; Shanafelt, TD; Strom, SS; Camp, NJ; Weinberg, JB; Matutes, E; Caporaso, NE; Wade, R; Dyer, MJS; Dearden, C; Cerhan, JR; Catovsky, D; Houlston, RSJournal Article
3-Jun-2010Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell - mediated B-cell cytotoxicityMössner, E; Brünker, P; Moser, S; Püntener, U; Schmidt, C; Herter, S; Grau, R; Gerdes, C; Nopora, A; Van Puijenbroek E; Ferrara, C; Sondermann, P; Jäger, C; Klein, C; Umaña, P; Strein, P; Fertig, G; Friess, T; Schüll, C; Bauer, S; Dal Porto J; Del Nagro C; Dabbagh, K; Dyer, MJS; Poppema, SJournal Article
1-Jul-2010Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocolCario, G; Romey, R; Schrauder, A; Moericke, A; Schrappe, M; Stanulla, M; Zimmermann, M; Gesk, S; Vater, I; Siebert, R; Harbott, J; Izraeli, S; Akasaka, T; Dyer, MJSJournal Article
Sep-2010Proteomic analysis of B-cell malignanciesBoyd, RS; Dyer, MJS; Cain, KJournal Article